| Product Code: ETC9961630 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Cancer Therapy Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Cancer Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Cancer Therapy Market - Industry Life Cycle |
3.4 United States (US) Cancer Therapy Market - Porter's Five Forces |
3.5 United States (US) Cancer Therapy Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 United States (US) Cancer Therapy Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 United States (US) Cancer Therapy Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Cancer Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in the US |
4.2.2 Technological advancements in cancer therapy |
4.2.3 Rising demand for personalized and targeted therapies |
4.2.4 Growing investments in research and development for cancer treatments |
4.3 Market Restraints |
4.3.1 High cost of cancer therapies and treatments |
4.3.2 Stringent regulatory requirements for approval of new therapies |
4.3.3 Limited access to advanced cancer therapies in certain regions |
4.3.4 Increasing concerns about the side effects of cancer treatments |
5 United States (US) Cancer Therapy Market Trends |
6 United States (US) Cancer Therapy Market, By Types |
6.1 United States (US) Cancer Therapy Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Cancer Therapy Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 United States (US) Cancer Therapy Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.4 United States (US) Cancer Therapy Market Revenues & Volume, By Target Therapy, 2021- 2031F |
6.1.5 United States (US) Cancer Therapy Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.1.6 United States (US) Cancer Therapy Market Revenues & Volume, By Hormone Therapy, 2021- 2031F |
6.1.7 United States (US) Cancer Therapy Market Revenues & Volume, By Other Treatment Types, 2021- 2031F |
6.2 United States (US) Cancer Therapy Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Cancer Therapy Market Revenues & Volume, By Blood Cancer, 2021- 2031F |
6.2.3 United States (US) Cancer Therapy Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.4 United States (US) Cancer Therapy Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.5 United States (US) Cancer Therapy Market Revenues & Volume, By Gastrointestinal Cancer, 2021- 2031F |
6.2.6 United States (US) Cancer Therapy Market Revenues & Volume, By Gynecologic Cancer, 2021- 2031F |
6.2.7 United States (US) Cancer Therapy Market Revenues & Volume, By Respiratory/Lung Cancer, 2021- 2031F |
6.3 United States (US) Cancer Therapy Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Cancer Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United States (US) Cancer Therapy Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.4 United States (US) Cancer Therapy Market Revenues & Volume, By Cancer and Radiation Therapy Center, 2021- 2031F |
7 United States (US) Cancer Therapy Market Import-Export Trade Statistics |
7.1 United States (US) Cancer Therapy Market Export to Major Countries |
7.2 United States (US) Cancer Therapy Market Imports from Major Countries |
8 United States (US) Cancer Therapy Market Key Performance Indicators |
8.1 Patient survival rates post-cancer therapy |
8.2 Adoption rates of innovative cancer therapies |
8.3 Number of clinical trials for cancer treatments |
8.4 Rate of approval for new cancer therapies |
8.5 Patient satisfaction and quality of life post-cancer therapy |
9 United States (US) Cancer Therapy Market - Opportunity Assessment |
9.1 United States (US) Cancer Therapy Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 United States (US) Cancer Therapy Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 United States (US) Cancer Therapy Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Cancer Therapy Market - Competitive Landscape |
10.1 United States (US) Cancer Therapy Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Cancer Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here